Cytori Therapeutics, Inc. (CYTX) Reports 2012 Business and Financial Results; Provides Outlook for 2013
3/8/2013 6:19:52 AM
Cytori Therapeutics (NASDAQ: CYTX) reports its 2012 business and financial results and provides an outlook for 2013. The Company achieved record total revenues for the year and fourth quarter ended December 31, 2012 of $14.5 million and $7.3 million, respectively, compared to $10.0 million and $2.8 million, respectively, for the same periods in 2011.
comments powered by